Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 401


Measuring Health and Broader Well-Being Benefits in the Context of Opiate Dependence: The Psychometric Performance of the ICECAP-A and the EQ-5D-5L.

Goranitis I, Coast J, Day E, Copello A, Freemantle N, Seddon J, Bennett C, Frew E.

Value Health. 2016 Sep - Oct;19(6):820-828. doi: 10.1016/j.jval.2016.04.010.


Short-term outcome of substance-induced psychotic disorder in a large UK first episode psychosis cohort.

Thompson A, Marwaha S, Winsper C, Everard L, Jones PB, Fowler D, Amos T, Freemantle N, Singh SP, Marshall M, Sharma V, Birchwood M.

Acta Psychiatr Scand. 2016 Oct;134(4):321-8. doi: 10.1111/acps.12623. Epub 2016 Aug 1.


Vaccination planning in Italy: increasing vaccines while reducing coverage?

Garattini L, Curto A, Freemantle N.

Expert Rev Pharmacoecon Outcomes Res. 2016 Oct;16(5):547-548. No abstract available.


Ophthalmic statistics note 10: data transformations.

Bunce C, Stephenson J, Doré CJ, Freemantle N; Ophthalmic Statistics Group.

Br J Ophthalmol. 2016 Jul 18. pii: bjophthalmol-2016-308824. doi: 10.1136/bjophthalmol-2016-308824. [Epub ahead of print] No abstract available.


Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999-2014.

Hatswell AJ, Baio G, Berlin JA, Irs A, Freemantle N.

BMJ Open. 2016 Jun 30;6(6):e011666. doi: 10.1136/bmjopen-2016-011666.


Challenges, solutions and future directions in the evaluation of service innovations in health care and public health.

Raine R, Fitzpatrick R, Barratt H, Bevan G, Black N, Boaden R, Bower P, Campbell M, Denis JL, Devers K, Dixon-Woods M, Fallowfield L, Forder J, Foy R, Freemantle N, Fulop NJ, Gibbons E, Gillies C, Goulding L, Grieve R, Grimshaw J, Howarth E, Lilford RJ, McDonald R, Moore G, Moore L, Newhouse R, O’Cathain A, Or Z, Papoutsi C, Prady S, Rycroft-Malone J, Sekhon J, Turner S, Watson SI, Zwarenstein M.

Southampton (UK): NIHR Journals Library; 2016 May.


Pursuit of truly independent data monitoring committees in research.

Marston L, McKenzie DR, Freemantle N.

BMJ. 2016 May 12;353:i2309. doi: 10.1136/bmj.i2309. No abstract available.


Beliefs of Health Care Providers, Lay Health Care Providers and Lay Persons in Nigeria Regarding Hypertension. A Systematic Mixed Studies Review.

Akinlua JT, Meakin R, Fadahunsi P, Freemantle N.

PLoS One. 2016 May 5;11(5):e0154287. doi: 10.1371/journal.pone.0154287. eCollection 2016.


Don't turn your back on the symptoms of psychosis: the results of a proof-of-principle, quasi-experimental intervention to reduce duration of untreated psychosis.

Connor C, Birchwood M, Freemantle N, Palmer C, Channa S, Barker C, Patterson P, Singh S.

BMC Psychiatry. 2016 May 4;16:127. doi: 10.1186/s12888-016-0816-7.


The course of negative symptom in first episode psychosis and the relationship with social recovery.

Gee B, Hodgekins J, Fowler D, Marshall M, Everard L, Lester H, Jones PB, Amos T, P Singh S, Sharma V, Freemantle N, Birchwood M.

Schizophr Res. 2016 Jul;174(1-3):165-71. doi: 10.1016/j.schres.2016.04.017. Epub 2016 Apr 28.


Ophthalmic statistics note 9: parametric versus non-parametric methods for data analysis.

Skene SS, Bunce C, Freemantle N, Doré CJ; Ophthalmic Statistics Group.

Br J Ophthalmol. 2016 Apr 27. pii: bjophthalmol-2015-308252. doi: 10.1136/bjophthalmol-2015-308252. [Epub ahead of print] No abstract available.


BMI upon discharge from hospital and its relationship with survival: an observational study utilising linked patient records.

Freemantle N, Ray D, Falcaro M, McNulty D, Shallcross L, Wood J, Pagano D.

J R Soc Med. 2016 Apr 6. pii: 0141076816639047. [Epub ahead of print]


Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records.

Petersen I, McCrea RL, Sammon CJ, Osborn DP, Evans SJ, Cowen PJ, Freemantle N, Nazareth I.

Health Technol Assess. 2016 Mar;20(23):1-176. doi: 10.3310/hta20230.


Results and lessons from the Spironolactone To Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (STOP-CKD) randomised controlled trial.

Ng KP, Jain P, Gill PS, Heer G, Townend JN, Freemantle N, Greenfield S, McManus RJ, Ferro CJ.

BMJ Open. 2016 Feb 25;6(2):e010519. doi: 10.1136/bmjopen-2015-010519.


Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison.

Freemantle N, Ginsberg DA, McCool R, Fleetwood K, Arber M, Khalaf K, Loveman C, Ni Q, Glanville J.

BMJ Open. 2016 Feb 23;6(2):e009122. doi: 10.1136/bmjopen-2015-009122.


Author's reply to Goldacre.

Freemantle N.

BMJ. 2016 Feb 17;352:i889. doi: 10.1136/bmj.i889. No abstract available.


Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis.

Freemantle N, Chou E, Frois C, Zhuo D, Lehmacher W, Vlajnic A, Wang H, Chung HW, Zhang Q, Wu E, Gerrits C.

BMJ Open. 2016 Feb 15;6(2):e009421. doi: 10.1136/bmjopen-2015-009421.


Pharmaceutical Price Schemes in Europe: Time for a 'Continental' One?

Garattini L, Curto A, Freemantle N.

Pharmacoeconomics. 2016 May;34(5):423-6. doi: 10.1007/s40273-015-0377-5. No abstract available.


Ophthalmic statistics note 8: missing data--exploring the unknown.

Bunce C, Quartilho A, Freemantle N, Doré CJ; Ophthalmic Statistics Group.

Br J Ophthalmol. 2016 Mar;100(3):291-4. doi: 10.1136/bjophthalmol-2015-307821. Epub 2015 Dec 30. No abstract available.

Items per page

Supplemental Content

Loading ...
Support Center